Bristol Gate Capital Partners Inc. raised its stake in Dow Chemical Co. (NYSE:DOW) by 3.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 514,766 shares of the company’s stock after buying an additional 15,169 shares during the period. Dow Chemical makes up approximately 4.6% of Bristol Gate Capital Partners Inc.’s investment portfolio, making the stock its 19th largest position. Bristol Gate Capital Partners Inc.’s holdings in Dow Chemical were worth $26,680,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of DOW. Stokes & Hubbell Capital Management LLC raised its position in shares of Dow Chemical by 0.3% in the second quarter. Stokes & Hubbell Capital Management LLC now owns 5,965 shares of the company’s stock valued at $297,000 after buying an additional 16 shares during the last quarter. Capital Management Corp VA raised its position in shares of Dow Chemical by 0.4% in the second quarter. Capital Management Corp VA now owns 4,433 shares of the company’s stock valued at $220,000 after buying an additional 16 shares during the last quarter. Gemmer Asset Management LLC raised its position in shares of Dow Chemical by 0.3% in the second quarter. Gemmer Asset Management LLC now owns 6,248 shares of the company’s stock valued at $311,000 after buying an additional 19 shares during the last quarter. Mark Sheptoff Financial Planning LLC raised its position in shares of Dow Chemical by 0.7% in the second quarter. Mark Sheptoff Financial Planning LLC now owns 2,938 shares of the company’s stock valued at $146,000 after buying an additional 19 shares during the last quarter. Finally, San Francisco Sentry Investment Group CA raised its position in shares of Dow Chemical by 0.4% in the second quarter. San Francisco Sentry Investment Group CA now owns 5,337 shares of the company’s stock valued at $265,000 after buying an additional 19 shares during the last quarter. 67.89% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Dow Chemical (NYSE:DOW)

Dow Chemical Co. (NYSE:DOW) traded down 0.75% during trading on Tuesday, hitting $53.91. The company had a trading volume of 1,216,415 shares. Dow Chemical Co. has a one year low of $40.26 and a one year high of $57.10. The company has a market capitalization of $60.45 billion, a price-to-earnings ratio of 8.40 and a beta of 1.20. The stock has a 50-day moving average of $53.69 and a 200 day moving average of $52.77.

Dow Chemical (NYSE:DOW) last released its earnings results on Thursday, October 27th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.79 by $0.12. Dow Chemical had a return on equity of 17.81% and a net margin of 16.91%. The business had revenue of $12.48 billion for the quarter, compared to analyst estimates of $12.01 billion. During the same quarter in the prior year, the company posted $0.82 earnings per share. Dow Chemical’s revenue was up 3.7% on a year-over-year basis. Equities analysts forecast that Dow Chemical Co. will post $3.65 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This news story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of United States and international copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2016/11/29/dow-chemical-co-dow-shares-bought-by-bristol-gate-capital-partners-inc.html.

Several brokerages have weighed in on DOW. RBC Capital Markets reaffirmed a “top pick” rating and issued a $68.00 target price (up from $65.00) on shares of Dow Chemical in a research report on Friday, October 28th. Vetr raised Dow Chemical from a “sell” rating to a “hold” rating and set a $51.12 price objective on the stock in a report on Monday, August 15th. Zacks Investment Research lowered Dow Chemical from a “buy” rating to a “hold” rating in a report on Wednesday, November 2nd. Citigroup Inc. raised Dow Chemical from a “neutral” rating to a “buy” rating and increased their price objective for the company from $55.00 to $59.00 in a report on Monday, October 3rd. Finally, Royal Bank Of Canada increased their price objective on Dow Chemical from $65.00 to $68.00 and gave the company a “top pick” rating in a report on Friday, October 28th. One analyst has rated the stock with a sell rating, three have given a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $61.21.

Dow Chemical Company Profile

5 Day Chart for NYSE:DOW

Receive News & Stock Ratings for Dow Chemical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical Co. and related stocks with our FREE daily email newsletter.